Firm Sued Over Fees To Preempt Malpractice Claims: Lab Co.

Law360, New York (June 13, 2012, 7:57 PM EDT) -- Unigene Laboratories Inc. blasted Ostrolenk Faber LLP on Tuesday, calling the intellectual property boutique's New York federal court suit over $400,000 in unpaid fees a “transparent” attempt to head off an impending malpractice suit.

New York-based Ostrolenk filed that suit late last month, claiming it had repped Unigene for more than 18 years before the pharmaceutical company abruptly terminated their agreement and refused to pay its outstanding balance.

But Unigene said Tuesday that the suit was little more than a distraction, a preemptive strike before Unigene...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Ostrolenk Faber LLP v. Unigene Laboratories, Inc. et al


Case Number

1:12-cv-03991

Court

New York Southern

Nature of Suit

Contract: Other

Judge

Harold Baer

Date Filed

May 18, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.